Learn More
Abcam Bufalin, Na+/K+-ATPase Inhibitor, Solid, >98% Purity, 50 mg
Description
- Molecular Weight: 386.5 Da
- Purity: >98%
- Form: Solid
- Mechanism of Action: Na+/K+-ATPase inhibitor; potent inhibitor of steroid receptor coactivators SRC-3 and SRC-1
- Biological Activity: Induces cell differentiation and apoptosis; activates AP-1 via JNK; shows antitumor effects in vivo
- Composition: 100% 3β-14-Dihydroxy-5β-bufa-20,22-dienolide
The product is subject to the following: Abcam Restricted Use Statement
Specifications
Specifications
| Content And Storage | Store at -20°C. |
| Form | Solid |
| Shipping Condition | Ambient |
| Substrate Properties | Chemical Substrate |
| Buffer | 100% 3β-14-dihydroxy-5β-bufa-20,22-dienolide |
| Target Molecule | Na+/K+-ATPase, SRC-3, SRC-1 |
| Formulation | 100% 3β-14-Dihydroxy-5β-bufa-20,22-dienolide |
| Quantity | 50 mg |
| For Use With (Application) | Na+/K+-ATPase inhibition, SRC-3 and SRC-1 inhibition, Induction of cell differentiation and apoptosis, AP-1 activation |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.